Detailed data show Pfizer’s monthly obesity drug continues to show potential Therapy acquired from Metsera is being closely watched

https://www.statnews.com/2026/06/06/pfizer-obesity-drug-berobenatide-metsera-results/ By Elaine ChenJune 6, 2026 Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.